Synopsis for October 12, 2006

The MMWR is embargoed until Thursday, 12 PM EST.

1. National Action Week for the Bone and Joint Decade – October 12-20, 2006
2. Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation – United States, 2003-2004 Years – United States, 2004-05
3. Vaccine-Derived Polioviruses – Worldwide, 1962-2006

National Action Week for the Bone and Joint Decade – October 12-20, 2006

No Summary Available

Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation – United States, 2003-2004 Years – United States, 2004-05

Arthritis affects over 46 million US adults and limits the activity for over 17 million. Increasing physical activity, losing weight and arthritis self-management education can decrease pain and improve function for people with arthritis. Arthritis affects 1 in 5, or 46 million, US adults, making it one of the most common chronic conditions. Over 38 percent, or 17 million, adults with arthritis are limited in their activities because of their arthritis. Women, older adults and racial/ethnic minorities are disproportionately affected. Increasing physical activity, losing excess weight, and participating in self-management education classes have been shown to reduce pain, improve functional limitations and mental health, and reduce disability among persons with arthritis. Increasing the availability of these evidence-based interventions in the community should be a critical public health goal.

Vaccine-Derived Polioviruses – Worldwide, 1962-2006

VDPVs are rare, and their spread can be prevented by high polio vaccine coverage. After wild poliovirus eradication, orderly cessation of OPV use will minimize the risk of VDPV emergence. The oral poliovirus vaccine (OPV) is the primary tool used to eradicate polio worldwide. Two primary categories of vaccine-derived polioviruses (VDPVs) resembling wild polioviruses have been identified. Both of these VPDVs are rare. Since 1961 only 30 of these VPDVs have been recognized and only eight outbreaks have been identified in the past. Most iVDPV infections cease spontaneously, and all cVDPV outbreaks have been rapidly controlled by OPV campaigns. Sensitive laboratory methods have also been developed to support global surveillance for VDPVs. The potential for VDPV emergence will continue as long as OPV is used. Therefore, continued development and implementation of a comprehensive strategy to minimize the risks of VDPV emergence through high polio vaccine coverage remains a high priority.

Department of Health and Human Services

Media Home | Contact Us
CDC Home | Search | Health Topics A-Z

This page last reviewed November 9, 2006

Centers for Disease Control and Prevention
Office of Communication